Holen Sie sich die Stockscreener-App
8.18
0.49%
-0.04
Handel nachbörslich:
8.20
0.02
+0.24%
Schlusskurs vom Vortag:
$8.22
Offen:
$8.43
24-Stunden-Volumen:
18,904
Relative Volume:
0.29
Marktkapitalisierung:
$312.94M
Einnahmen:
$4.71M
Nettoeinkommen (Verlust:
$-46.77M
KGV:
-4.6721
EPS:
-1.7508
Netto-Cashflow:
$-60.34M
1W Leistung:
-10.41%
1M Leistung:
-14.17%
6M Leistung:
-19.01%
1J Leistung:
+62.95%
1-Tages-Spanne:
$8.13
$8.43
1-Wochen-Bereich:
$8.10
$9.32
52-Wochen-Spanne:
$4.00
$20.00
Nyxoah Sa Stock (NYXH) Company Profile
Vergleichen Sie NYXH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| NYXH | 8.18 | 312.94M | 4.71M | -46.77M | -60.34M | -1.7508 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Nyxoah’s Voting Rights Shift with ResMed Stake - TipRanks
Publication relating to transparency notifications - GlobeNewswire
ResMed's Stake in Nyxoah Drops Below 5% Threshold in Latest Holdings Update | NYXH Stock News - StockTitan
Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 17.4% in October - MarketBeat
Nyxoah's SWOT analysis: sleep apnea device maker's stock poised for growth - Investing.com India
Nyxoah Third Quarter 2024 Earnings: €0.50 loss per share (vs €0.27 loss in 3Q 2023) - Simply Wall St
Nyxoah sales jump 30% to €1.3 million in Q3 2024 - Medical Buyer
Nyxoah SA Reports Growth Amid Clinical Advances - TipRanks
Nyxoah Reports Third Quarter Financial and Operating Results - The Korea Bizwire
EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results - sharewise
Nyxoah Eyes Strong US Launch Amid Financial Growth - TipRanks
Nyxoah S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Nyxoah - Via Ritzau
(NYXH) Investment Report - Stock Traders Daily
Nyxoah SA (NYXH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Nyxoah SA Announces CFO Changes - Marketscreener.com
Nyxoah participates in a conference call with Cantor Fitzgerald - TipRanks
Nyxoah Appoints John Landry as Chief Financial Officer - The Manila Times
Nyxoah Strengthens Leadership for U.S. and Global Expansion - TipRanks
Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - MSN
Trend Tracker for (NYXH) - Stock Traders Daily
Publication relating to transparency notifications: Nyxoah - The Korea Bizwire
Transparency Notification: Vestal Point Capital’s Stake in Nyxoah - PanAsiaBiz
NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024, Business Wires News - AsiaOne
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 - The Manila Times
Behind the Bell: Nyxoah SA - Nasdaq
Nyxoah raises $27M for US commercialization of sleep apnea technology - BioWorld Online
How To Trade (NYXH) - Stock Traders Daily
Nyxoah Shareholdings Shift: Hambrecht and BlackRock Update - TipRanks
Nyxoah (NASDAQ:NYXH) Price Target Cut to $17.00 - Defense World
Nyxoah shares price target cut by H.C. Wainwright - Investing.com India
HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $17.00 - MarketBeat
Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference, Business Wires News - AsiaOne
Nyxoah price target lowered to $17 from $18 at H.C. Wainwright - TipRanks
Nyxoah Raises $27M Through US Healthcare Investor to Support Genio Launch - Sleep Review
Information on the Total Number of Voting Rights And Shares: Nyxoah - The Korea Bizwire
Publication Relating to Transparency Notifications: Nyxoah - The Korea Bizwire
BlackRock Acquires 3.25% Stake in Nyxoah SA - TipRanks
Nyxoah SA (NYXH) Q2 2024 Earnings Call Highlights: Strategic Growth and US Market Preparations By GuruFocus - Investing.com Canada
Information on the total number of voting rights and shares - GlobeNewswire
Nyxoah Secures $27 Million to Boost U.S. Presence - Yahoo Finance
Ratio Revelations: Nyxoah SA (NYXH)’s Financial Metrics in the Spotlight - The Dwinnex
Nyxoah sells 3 million shares, raises USD 27 million - Medical Buyer
Nyxoah Secures $27 Million for U.S. Market Expansion - TipRanks
Nyxoah Raises $27 Million through its At-the-Market Offering - GlobeNewswire
Contrasting PetVivo (NASDAQ:PETV) and Nyxoah (NASDAQ:NYXH) - Defense World
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.70%
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):